Company Filing History:
1 out of 484 
1 out of 2,340 
Years Active: 2014
Title: Arsen Gaysin: Innovator in Cancer Treatment
Introduction
Arsen Gaysin is a notable inventor based in Berwyn, Illinois, recognized for his contributions to the field of cancer treatment. He holds a patent for isoform-selective HDAC inhibitors, which have significant implications for cancer therapy and other diseases.
Latest Patents
Gaysin's patent focuses on isoform-selective HDAC inhibitors. One aspect of this invention relates to methods of sensitizing cancer cells to the cytotoxic effects of radiotherapy. The invention also encompasses methods for treating cancer, neurological diseases, and malaria. Additionally, it provides pharmaceutical compositions and kits that include an HDAC inhibitor.
Career Highlights
Throughout his career, Gaysin has worked with prestigious institutions such as Georgetown University and the University of Illinois. His research has contributed to advancements in medical treatments and therapeutic strategies.
Collaborations
Some of his notable coworkers include Alan P. Kozikowski and Mira Jung, who have collaborated with him on various research projects.
Conclusion
Arsen Gaysin's innovative work in developing isoform-selective HDAC inhibitors showcases his commitment to improving cancer treatment and addressing other significant health challenges. His contributions continue to influence the medical field positively.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.